Recombinant Mouse MMP-9, CF

Name	Recombinant Mouse MMP-9, CF
Supplier	R&D Systems
Catalog	909-MM-010
Category	Protein
Nature	Recombinant
Source	Mouse myeloma cell line, NS0-derived, Ala20-Pro730
Purity	>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
SwissProt/Accession	P41245
Gene	Mmp9
Supplier Page	Shop

Product References

In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 - In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9

Song J, Wu C, Zhang X, Sorokin LM. J Immunol. 2013 Jan 1;190(1):401-10.

Ocular neovascularization caused by herpes simplex virus type 1 infection results - Ocular neovascularization caused by herpes simplex virus type 1 infection results

Suryawanshi A, Mulik S, Sharma S, Reddy PB, Sehrawat S, Rouse BT. J Immunol. 2011 Mar 15;186(6):3653-65.

A novel proteolytic cascade generates an extracellular matrix-derived - A novel proteolytic cascade generates an extracellular matrix-derived

Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB, Rowe SM, Clancy JP, Blalock JE. J Immunol. 2008 Apr 15;180(8):5662-9.

The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice - The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice

Le Quement C, Guenon I, Gillon JY, Valenca S, Cayron-Elizondo V, Lagente V, Boichot E. Br J Pharmacol. 2008 Jul;154(6):1206-15.

A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via - A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via

Rafei M, Wu JH, Annabi B, Lejeune L, Francois M, Galipeau J. Blood. 2007 Mar 1;109(5):2234-42. Epub 2006 Nov 2.

Activity-dependent release of precursor nerve growth factor, conversion to mature - Activity-dependent release of precursor nerve growth factor, conversion to mature

Bruno MA, Cuello AC. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6735-40. Epub 2006 Apr 17.

Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated - Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated

Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. J Clin Invest. 2003 Nov;112(9):1318-31.